CFMG & Wellpath in California — a documentary investigation · Article 029 of 100 · Series 3 — Physician executives, ownership and succession

Did CFMG Own Wellpath LLC? The Federal 'Corporate Parent' Disclosure Anomaly

Published

20 September 2026, 6:00 PM PT

Content last changed

20 September 2026, 6:00 PM PT

Public-evidence cutoff

20 September 2026, 6:00 PM PT

Sources checked

20 September 2026, 6:00 PM PT

Record through

20 September 2026, 6:00 PM PT

Editorial status

Public-source editorial review complete

Evidence note. This article relies on public records and distinguishes established fact, party position, allegation, judicial finding, inference and unresolved question. Nothing here is a finding that any identified corporation or individual violated California law unless a cited adjudicative source expressly says so.

Opening frame#

Did CFMG Own Wellpath LLC? The Federal 'Corporate Parent' Disclosure Anomaly is a governance inquiry, not a title-matching exercise. Corporate office, medical leadership, stock ownership, enterprise employment, and practical decision authority are treated as distinct evidentiary categories. The record is strongest where those categories converge in executed documents and weakest where succession or ownership instruments remain unavailable.

The governing question is narrow: How should repeated defense-side Rule 7.1 parent disclosures be reconciled with bankruptcy and affiliate records? The article connects that question to juridical identity, operational integration, professional authority, ownership and succession, practical exit rights, and demonstrated veto power only where the evidence makes those connections material.

I. The Question and the Public Record#

The relevant public record is best read cumulatively. No single branding statement, county agenda item, corporate filing, bankruptcy disclosure, or management agreement resolves the entire relationship. The evidentiary value comes from comparing documents created for different purposes and asking whether they converge on the same allocation of identity, authority, economics, and professional responsibility.

Wellpath now publicly describes CFMG as a physician-owned affiliate#

In March 2026, Wellpath announced a new California-focused operating division called Local Government-California . In the same release, Wellpath called CFMG a Wellpath affiliate and stated in a footnote that CFMG is a professional corporation owned by licensed physicians and affiliated with Wellpath’s management-services organization. Wellpath also described the use of enterprise data infrastructure across its affiliates. Source: Wellpath, Mar. 13, 2026

That is the company’s current public description of the relationship. It is useful evidence of how Wellpath describes the architecture; it is not independent proof of the identity of CFMG’s individual shareholders or of how professional authority functions in every decision.

A. Why these filings matter#

Federal Rule of Civil Procedure 7.1 and district-local disclosure rules require parties to disclose certain corporate relationships and interested entities. These filings are not ordinary marketing copy. They are counsel-filed representations designed to identify relationships relevant to recusal, ownership, and conflicts.

That makes the CFMG/Wellpath disclosure record potentially important.

At the same time, docket text can be generated from fields entered into ECF and may not perfectly reproduce the legal nuance of the underlying form. Therefore the underlying filed PDF must be obtained and reviewed before publication of any ownership conclusion .

Why this is analytically important#

If the underlying filings truly say what the docket text says, the record raises an obvious question:

How could a California physician-owned professional corporation be identified in federal corporate-disclosure filings as the “corporate parent” of Wellpath LLC, a national management entity, while public corporate materials describe CFMG as a Wellpath affiliate?

There may be an innocent explanation: ECF relationship categories may have been selected imperfectly, the disclosure might have been drafted for conflicts purposes rather than corporate genealogy, or docket metadata may compress a more nuanced statement.

the record must not turn this into an accusation before reviewing the filings themselves.

But the repetition across more than one case means the issue is sufficiently concrete to justify a dedicated source-retrieval project.

open question: Very High.

Requested source set:

• exact PDF of interested-entity/corporate-disclosure filings in Beckner ;

• exact filings in Sand ;

• exact filings in Strieter ;

• exact filings in Avila ;

• equivalent filings in Venegas , Kukar-Tekano , Ayala , Pugh , and current CFMG cases.

The output should be a year-by-year table showing the relationship box or terminology actually used.

The contract record shows a recurring county-side misdescription#

Multiple county/public sources use formulations such as:

• “CFMG dba Wellpath”

• “CFMG/Wellpath”

• “CFMG, now Wellpath”

• “Wellpath, formerly CFMG”

• “CFMG dba Wellpath Management, Inc.”

• “CFMG commonly known as Wellpath”

These formulations should not be collapsed into one legal proposition.

They may represent:

• brand usage;

• County shorthand;

• vendor-system nomenclature;

• mistaken corporate succession assumptions;

• or actual contractual DBA language.

The federal bankruptcy record proves why this matters: CFMG remained a distinct professional corporation.

Thus county nomenclature is best treated as:

evidence of how the healthcare operation presented itself and was understood by the governmental client.

That is highly relevant to operational identity.

It is not enough to establish corporate genealogy.

The bankruptcy record also contains the strongest structural investigative evidence yet#

The same record identifies facts that require deeper review:

• Wellpath itself calls the model a friendly professional corporation structure.

• The PCs generated more than $674 million in annual revenue for the benefit of the Debtors .

• The Debtors remitted approximately $720 million in PC operating costs.

• The Debtors collected certain PC receivables.

• The Debtors handled payroll, benefits, taxes, and deductions for PC employees.

• The Debtors and certain physician owners were parties to Stock Transfer Agreements.

• Those agreements restricted transfer of physician shares.

• The stated purpose included continuation of the Debtors’ administrative services.

• The Debtors said they had authority under those agreements to ensure PCs remained licensed and qualified.

• The Debtors argued that Professional Corporation Contracts and organizational documents were executory contracts involving estate interests.

• The Debtors said they “maintain an interest” in the PCs.

• The motion uses the facially inconsistent phrase “ownership interests in the Professional Corporations.”

• The Debtors considered continued PC relationships essential to their own reorganization.

• New PC contracts during bankruptcy required five-business-day notice to DIP lenders and the Ad Hoc Group.

• CFMG litigation was sufficiently economically connected to Wellpath through insurance and indemnity that the Debtors repeatedly sought stay protection.

• No public CFMG-specific board record has yet been found showing an independent decision to continue with Wellpath during or after the restructuring.

None of these facts alone establishes unlawful control.

Together, they make the stock-transfer and board records indispensable.

The december 2018 county record is one of the earliest public examples of CFMG/Wellpath identity blending#

Only months after CFMG began operating the Fresno contract, a Fresno County behavioral-health advisory record stated that a name change had recently occurred from CFMG to Wellpath, while also stating that the organization would continue to operate under CFMG and the Fresno contract would remain with CFMG .

The same County record referred to the Fresno agreement as the largest Wellpath contract and described Wellpath operational personnel, including a regional operations director.

Primary County minutes:

https://www.fresnocountyca.gov/files/sharedassets/county/v/1/vision-files/files/35776-dec-2018-minutes.pdf

This is exceptionally useful because it documents the identity ambiguity essentially at the moment it arose.

The County’s language can be summarized:

Public operating name changed to Wellpath; legal contract remained CFMG.

The “name change” wording should not be interpreted as an actual corporate conversion.

Later federal cases and bankruptcy records establish that CFMG did not simply change its legal name to Wellpath.

But the County record explains why employees, patients, counsel, and courts later used the names interchangeably.

II. Structural and Historical Context#

Records that would resolve the question#

• Actual Rule 7.1 / interested-entity PDFs from Beckner , Sand , Avila , Strieter , and post-bankruptcy CFMG cases.

• Every Overfield exhibit concerning Chapman termination.

• Chapman’s continued deposition once filed.

• Any renewed Hole deposition.

• Complete Smith same-entity stipulation and financial discovery record.

• Complete D.M. discovery correspondence supporting the same-functions representation.

• Complete Andrew Ho bankruptcy/arbitration references; public filings only.

• Napa Agreement 190201B and every amendment.

• County-by-county executed agreements and RFP proposals.

• CFMG/Wellpath quality-review policies implicated by Kartchner .

• Bankruptcy insurance/indemnity schedules naming CFMG.

• The 2012 MSA exhibits and every later amendment.

• All stock-transfer restriction / succession instruments referenced by the 2019 assignment.

• CFMG bylaws and shareholder/officer history.

• Physician employment templates pre-2018 vs post-2018.

• Wellpath enterprise clinical-policy approval matrices for California.

The january 1, 2019 assignment put Wellpath llc directly into the manager position#

The next essential instrument is the January 1, 2019 Assignment. It identifies CFMG as the “Company,” Wellpath LLC as the “Manager,” and Wellpath Management, Inc., formerly Correctional Medical Group Companies, Inc. / California Forensic Management Group, Inc., as the “Outgoing Manager.”

The assignment does not dissolve CFMG or replace it with Wellpath. Instead, it changes the party occupying the management side of the existing PC–MSO relationship. The outgoing manager irrevocably assigns the Management Services Agreement to Wellpath LLC together with related or incidental instruments, including relevant stock-transfer restriction agreements.

Primary source:

https://www.prisonlegalnews.org/media/publications/California\_Forensic\_Medical\_Group\_Assignment\_of\_Management\_Services\_Agreement.pdf

This creates the critical prepetition baseline:

CFMG professional corporation ↔ Wellpath LLC manager

not:

CFMG ↔ Wellpath Holdings.

That distinction becomes central in bankruptcy because the ultimate parent changed dramatically while Wellpath LLC itself remained the identified contracting manager .

Shareholder-succession event table to build once the agreement is found#

For every historical owner transfer:

The likely historical periods needing reconstruction are:

• founder era;

• 2012–2013 H.I.G. transaction;

• Fithian/Herr transition;

• 2018 CCS–CMGC combination;

• Herr/Bazzel transition;

• 2024 bankruptcy;

• 2025 lender emergence;

• 2026 Local Government–California restructuring.

The chronology should remain blank where ownership is unproven rather than inferring ownership from officer titles.

III. The Control and Governance Analysis#

Subpages#

• Corporate timeline: 1983–2026

• The 2012 Management Services Agreement

• H.I.G. Capital and the 2013 investment

• The 2018 CCS–CMGC transaction and creation of Wellpath

• The 2019 management assignment

• CFMG physician ownership and governance

• California county contracts

• Physician employment and HR control

• Physician compensation and payroll

• Medical records and EHR control

• Clinical policy and operational control

• Litigation defense and claims administration

• Pre-bankruptcy litigation positions

• Bankruptcy and the rediscovery of CFMG

• Post-bankruptcy California litigation

• Smith v. Santa Cruz County

• D.M. v. County of Merced

• Hernandez v. County of Monterey

• Overfield v. Wellpath / CFMG

• Fresno case study: Miles, Henderson, and J.S.

• California CPOM law and 2026 enforcement

• Evidence matrix

• Case index

• Primary-document library

• Open questions / records not yet public

Every page should include a visible Evidence Level badge and a What this does not prove section.

Domain four — utilization management, referrals, and diagnostic testing#

California’s rule is especially clear here: an unlicensed entity may not determine which diagnostic tests or referrals are medically appropriate.

The MSA says CFMG, in consultation with management, is responsible for developing and implementing utilization-review and quality-assurance guidelines and reserves individual physician professional judgment.

Yet Wellpath’s own 2020 ESG report says that, working with its “affiliate physician owned provider” CFMG, it provides California correctional-health services and “under our Management Services Agreement we also provide utilization management functions.”

Primary source:

https://wellpathcare.com/wp-content/uploads/2022/07/Wellpath-2020-ESG-Report.pdf

That public statement creates a concrete question:

What exactly were the Wellpath utilization-management functions, and who had final authority over medical necessity, specialty referrals, diagnostics, and patient-specific treatment resources?

The terminology does not itself prove a violation. Utilization management can include lawful tracking, network coordination, scheduling, cost data, utilization reporting, record gathering, transportation, and specialty-care facilitation.

It becomes professionally significant if the MSO can deny, condition, or override a physician’s decision that care is medically necessary.

High-value evidence includes UR policies, approval criteria, denial codes, referral workflows, specialty-request logs, appeal process, reviewer roster, employer/entity of reviewer, physician override mechanisms, and examples of treating-physician disagreement.

Current assessment: Wellpath publicly admits a utilization-management role; the MSA assigns CFMG responsibility for utilization-review guidelines; patient-specific final authority is not yet established.

Override Test: Find a referral or diagnostic request that utilization management questioned and determine whether the treating/CFMG physician could approve it anyway.

Cfmg's nondebtor status does not mean economic independence#

The bankruptcy makes an important analytical distinction possible.

CFMG was not simply a Wellpath debtor affiliate.

But Wellpath sought court authority to:

• honor obligations to professional corporations;

• continue professional-corporation contractual relationships;

• pay obligations processed under those relationships;

• obtain new professional-corporation contracts.

Wellpath argued that uninterrupted performance under PC management agreements was necessary to preserve the value of its business.

That is evidence of reciprocal operational dependence.

The professional corporations needed management infrastructure.

The Wellpath business needed the professional corporations through which licensed practice could occur in states requiring PC structures.

That reciprocal dependence is not inherently unlawful.

It does, however, explain why the PC–MSO relationship is economically central rather than incidental.

Cfmg’s principal office moved into the post-bankruptcy Wellpath headquarters#

By November 2025, CFMG’s California Secretary of State filing listed its principal office as:

6550 Carothers Parkway, Suite 500, Franklin, Tennessee 37067

which is Wellpath’s post-bankruptcy corporate headquarters.

That is strong evidence of administrative integration after emergence.

It does not prove stock ownership, clinical control, or loss of physician governance.

But it demonstrates that after the bankruptcy, CFMG’s formal administrative locus became physically embedded at the reorganized Wellpath headquarters.

This should be compared with board/governance records to determine how physician corporate actions were actually processed.

The bankruptcy motion explains how Wellpath’s stock-transfer agreements generally functioned#

The November 12, 2024 Professional Corporation Motion supplies the enterprise-level explanation.

Wellpath described its PC model as a “friendly professional corporation” structure in which professional entities were owned by licensed physicians while Wellpath supplied management and administrative services.

The filing says the debtors and certain physician owners were parties to Stock Transfer Agreements that:

• restricted transfer of professional-corporation stock;

• facilitated orderly ownership transitions;

• supported compliance with professional-entity laws;

• addressed transfer events such as death and disability;

• promoted continuity of care;

• and promoted continued administrative services by the Wellpath debtors.

The filing further states that the debtors possessed authority under those agreements to help ensure that the PCs remained properly licensed and qualified.

Primary source:

In re Wellpath Holdings, Inc., No. 24-90533, Docket No. 15 (Bankr. S.D. Tex. Nov. 12, 2024).

https://document.epiq11.com/document/getdocumentsbydocket/?docketId=1124325&docketNumber=15&projectCode=WPT&source=DM

These are major facts.

But the pleading refers generally to “certain PC Physicians.”

It does not say that every professional corporation had exactly the same transfer provisions.

Thus:

CFMG-specific assignment + enterprise-level description = strong reason to investigate, but not permission to invent the missing CFMG terms.

Current working thesis#

CFMG appears to be a real, legally distinct California professional corporation embedded within an exceptionally comprehensive Wellpath management architecture. Formal physician governance, county contracting, nondebtor status, and evidence of professional functions weigh against a simplistic shell-company theory. At the same time, Wellpath’s documented role reaches deeply into physician employment architecture, compensation, staffing, utilization management, records, finance, insurance, contracting, defense, and the succession machinery surrounding the professional-corporation model. The central unresolved question is not whether Wellpath owns CFMG stock—the current evidence does not establish that—but whether contractual and practical rights give the management enterprise power over who may own/control CFMG or over decisions California reserves to physicians.

IV. Contrary Evidence, Limits, and Competing Explanations#

A disciplined analysis must begin its limiting case with the strongest contrary evidence: The central limitation is the missing shareholder/stock-transfer record. Physician corporate titles are genuine governance evidence but are not proof of ownership or independence under disagreement.

Court confusion as a distinct research finding#

Across the cases reviewed, several forms of nomenclature confusion recur:

• CFMG “dba Wellpath”;

• CFMG “now Wellpath”;

• Wellpath as “successor”;

• Wellpath Management “formerly known as CFMG”;

• CFMG and Wellpath “same entity” for litigation purposes;

• CFMG “separate and distinct” post-bankruptcy;

• CFMG as a “subsidiary” in one stipulation;

• CFMG as apparent “corporate parent” in some ECF disclosure metadata;

• CFMG as “affiliate” in others.

The correct conclusion is not that courts failed universally to understand the structure.

The stronger conclusion is:

The corporate and branding architecture generated enough ambiguity that courts and litigants repeatedly adopted shorthand or entity descriptions that later required clarification.

This is objectively demonstrable and legally important because entity identity controls:

• service;

• discovery;

• liability;

• bankruptcy;

• insurance;

• judgment;

• employment status.

Why the name collision matters to the H.I.G. history#

H.I.G.'s January 7, 2013 press release said an H.I.G. affiliate made a "strategic investment in California Forensic Medical Group, Inc."

That public description is broad corporate shorthand.

It does not itself identify:

• which legal entity's stock was purchased;

• whether professional-corporation stock changed hands;

• what contractual rights accompanied the investment;

• whether investment occurred through a holding company or management entity.

The 2018 financing record is more technically specific.

It refers to acquisition of the capital stock of CFMG Holdings Corp.

Because the Wellpath bankruptcy later identifies Wellpath CFMG, Inc. as formerly CFMG Holdings Corp. , the better working hypothesis is:

H.I.G.'s economic investment in the "CFMG" enterprise appears to have involved a holding/management-side corporate structure distinct from the California professional corporation itself.

That is still a hypothesis requiring the acquisition documents and pre-2018 organization chart for complete confirmation.

It should replace loose public phrasing such as:

"H.I.G. bought the California medical corporation."

The evidence assembled to date does not justify that statement.

DHEERAJ TARANATH is distinct from THE VERIFIED CFMG BOARD#

Dr. Dheeraj Taranath is highly relevant to CFMG operations, but the current evidence does not establish him as a CFMG shareholder, director, or officer.

Wellpath's current leadership page identifies him as:

Chief Clinical Officer, Wellpath

The Wellpath bankruptcy plan likewise listed him among the officers of reorganized Wellpath as Chief Clinical Officer.

County materials in 2026 identify him as a Wellpath chief medical/clinical executive.

He has also communicated on CFMG-related matters.

But those facts do not put him on CFMG's board.

This distinction is important because loose shorthand of the form "physician shareholders and leadership" is easy to apply to any senior clinician associated with the enterprise, including Taranath.

For public publication, that shorthand must not become a factual assertion of share ownership.

The correct description is:

Wellpath Chief Clinical Officer who has participated in CFMG-related clinical/organizational matters; no current public proof of CFMG share ownership or board office identified.

V. Missing Documents and Falsification Tests#

The record remains incomplete in material respects. Key unresolved points include the actual shareholder ledger, stock-transfer agreement, succession minutes, and the explanation for contradictory parent/subsidiary/affiliate filings.

E. Madrid v. County of Tulare — a different post-bankruptcy description#

In July 2025, a stipulation states that plaintiff’s outside bankruptcy counsel advised that the correct defendant was:

“CALIFORNIA FORENSIC MEDICAL GROUP (CFMG), who is a subsidiary company of Wellpath Management Inc.”

The parties then stipulated to substitute CFMG and the Wellpath Liquidating Trust for Wellpath Management Inc.

Primary filing:

https://docs.justia.com/cases/federal/district-courts/california/caedce/1%3A2024cv00351/443900/37

The substitution is a procedural fact. The “subsidiary” statement is an attorney characterization embedded in the stipulation, not a judicial finding of ownership.

Still, it belongs in the record because it conflicts facially with the current corporate description of CFMG as a physician-owned professional corporation affiliated with a Wellpath MSO.

Research question:

What source did bankruptcy counsel rely on in calling CFMG a subsidiary?

The bankruptcy did not reorganize CFMG stock through the debtor plan#

Because CFMG was a nondebtor professional corporation, the Wellpath Chapter 11 did not simply convert CFMG stock into lender equity in the manner that debtor-company equity was restructured.

That distinction matters.

Wellpath itself announced in May 2025 that ownership of the reorganized Wellpath enterprise transitioned to a group of current and former lenders.

Public SEC filings by Prospect Capital show that its Wellpath debt was converted into debt and equity positions in New WPCC Parent, LLC . Prospect subsequently reported holdings including Series A Preferred Interests and Class A Common Interests in New WPCC Parent.

Those records illuminate the new ownership of the management enterprise.

They do not establish that New WPCC Parent owns CFMG's physician stock.

The more precise question is:

What happened to the MSA, stock-transfer restrictions, management rights, security interests, and succession mechanisms when the Wellpath management enterprise changed ownership?

That is the post-bankruptcy continuity issue.

The post-bankruptcy owner group is not yet fully mapped#

Wellpath's May 12, 2025 emergence announcement states that ownership transitioned to the Ad Hoc Lender Group .

SEC records show at least one lender/investor, Prospect Capital, holding:

• First Lien debt in New WPCC Parent;

• Series A Preferred Interests;

• Class A Common Interests;

• interests in the Wellpath liquidation trust.

Those records support the conclusion that the post-bankruptcy ownership structure differs materially from the old H.I.G.-sponsored structure.

But the complete cap table is not yet in the public corpus assembled here.

the prior analysis therefore should not describe Wellpath as still H.I.G.-owned after emergence.

Nor should it describe the reorganized entity as controlled by any single identified lender without proof.

The correct statement is:

Wellpath publicly transitioned to ownership by a group of current and former lenders, with New WPCC Parent, LLC appearing in SEC disclosures as the post-restructuring parent investment vehicle.

Shareholder#

The shareholder owns the professional corporation's stock.

Because CFMG is a California professional medical corporation, stock ownership is subject to California professional-corporation restrictions.

A shareholder's identity must be established through:

• stock ledger;

• stock certificate;

• shareholder agreement;

• transfer record;

• corporate minutes;

• authenticated corporate filing or admission.

A title alone is insufficient.

Where the missing stock documents may exist#

Potential repositories include:

• CFMG corporate minute book;

• corporate counsel records;

• Wellpath legal department;

• management-company contract repository;

• bankruptcy diligence/data room;

• H.I.G. transaction files;

• lender diligence files;

• UCC/collateral documentation;

• former officer records;

• county due-diligence submissions if ownership certifications were required;

• malpractice/insurance underwriting files;

• California regulatory filings;

• tax records.

The 2019 assignment proves that at least some stock-transfer restriction instruments existed.

That makes their absence from the public record a retrieval problem, not a reason to assume their contents.

THE 2025 RESTRUCTURING changed OWNERSHIP OF THE MANAGEMENT ENTERPRISE — not PROVEN CFMG STOCK OWNERSHIP#

Wellpath announced that it emerged from Chapter 11 in May 2025 and transitioned ownership to a group of its current and former lenders.

Primary Wellpath announcement:

https://wellpathcare.com/2025/05/12/wellpath-emerges-from-chapter-11-to-lead-a-new-era-in-correctional-healthcare/

Prospect Capital SEC filings independently confirm that its prepetition Wellpath debt was restructured on May 9, 2025 into new debt and equity positions in New WPCC Parent, LLC , plus an interest in the Wellpath Liquidating Trust.

Primary SEC record:

https://www.sec.gov/Archives/edgar/data/1287032/000128703226000164/psec-20260331.htm

Those records are important because they independently confirm the lender-to-equity restructuring.

They do not establish that New WPCC Parent acquired CFMG professional-corporation stock.

The entity distinction developed in the prior analysis remains critical:

New WPCC Parent / reorganized Wellpath enterprise ≠ automatically California Forensic Medical Group, Incorporated .

Any transfer of CFMG physician shares must be proved independently.

THE PLAN’S USE OF “Wellpath CFMG, INC.” is not THE CALIFORNIA PROFESSIONAL CORPORATION#

Post-restructuring corporate documents refer to ownership of entities including Wellpath CFMG, Inc.

As established in the prior analysis, Wellpath CFMG, Inc. is a separate holding/debtor-side entity associated historically with CFMG Holdings Corp.

It is not the same corporate name as:

California Forensic Medical Group, Incorporated

the California professional corporation.

This distinction matters enormously when reading restructuring documents.

A statement that New WPCC Parent indirectly acquired stock of Wellpath CFMG, Inc. is not evidence that lender owners acquired physician shares in the California PC.

the record should flag this distinction every time a “CFMG” acronym appears in bankruptcy materials.

High-priority bankruptcy documents for the next pass#

• Docket No. 194 and its complete potential-assumed-contract schedule.

• All supplements to Docket No. 194.

• Docket Nos. 2039, 2189, 2498, and 2551 rejection schedules.

• Plan Supplement Docket Nos. 2321 and 2555.

• First Amended Plan Docket No. 2376-1 and technical modifications Docket No. 2552-1.

• Schedule of assumed executory contracts at emergence.

• Any specific entry for the CFMG MSA.

• Any CFMG cure amount.

• Any notice served directly on CFMG.

• Any CFMG objection, reservation, consent, or response.

• Any stock-transfer agreement listed as executory.

• Any CFMG organizational document listed as executory.

• Any post-effective-date assumption/assignment of the CFMG MSA.

• New WPCC Parent LLC agreement.

• lender governance/board-appointment rights.

• restructuring-transaction steps involving Wellpath LLC / Wellpath Management.

• documents concerning Wellpath CFMG, Inc. f/k/a CFMG Holdings Corp. to preserve entity distinctions.

• CFMG board minutes November 2024–June 2025.

• CFMG shareholder minutes during restructuring.

• CFMG independent-counsel engagement records.

• post-emergence CFMG MSA amendments.

• 2026 Local Government–California authority/delegation records.

The bankruptcy record sharpens the central cpom question#

The bankruptcy evidence does not prove that Wellpath practiced medicine through CFMG.

It does something more useful.

It reveals the architecture of dependence .

The Debtors themselves described:

• a friendly-PC structure;

• physician ownership;

• deep administrative control;

• major economic reliance on PC revenues;

• stock-transfer restrictions tied to management continuity;

• authority relating to PC licensing/qualification;

• insurance;

• payroll;

• collections;

• taxes;

• legal support;

• indemnification;

• lender notice over new PC contracts.

California law then asks a separate question:

Did those structural rights and dependencies remain on the lawful administrative side of the line, or did they give the nonprofessional management enterprise practical or contractual authority over decisions reserved to physicians?

That question still requires the CFMG-specific stock, board, and authority records.

The restructuring changed the ultimate parent stack while preserving lower-level debtor entities unless specifically liquidated#

The Plan provides that, except as otherwise specified, each Debtor continues to exist after the Effective Date as a separate legal entity.

The final Restructuring Transactions Memorandum then identifies particular entities that were to liquidate. It expressly states:

• Step 11 — Wellpath Holdings liquidates.

• Step 12 — CCS-CMGC Intermediate Holdings, Inc., CCS-CMGC Intermediate Holdings 2, Inc., and CCS-CMGC Parent Holdings LP liquidate.

The restructuring memorandum does not identify Wellpath LLC among those entities in Steps 11–12. Instead, a new parent structure was created and received substantially all assets of Wellpath Holdings, including stock of Wellpath CFMG, Inc.

Primary source: Docket No. 2555, Restructuring Transactions Memorandum, pp. 241–243.

https://document.epiq11.com/document/getdocumentbycode?docId=4468244&projectCode=WPT&source=DM

This supports a critical entity-level conclusion:

The ownership above Wellpath LLC changed; there is no indication in the cited restructuring steps that the contracting entity Wellpath LLC itself was liquidated and replaced as CFMG’s manager.

That is exactly why a new public CFMG MSA assignment may not have been necessary.

Current confidence assessment#

2019 Assignment made Wellpath LLC the manager: Very High.

January 2019 CFMG MSA remained operative in February 2025: Very High.

Final Plan used blanket assumption as default: Very High.

California Forensic Medical Group absent from final searchable rejection schedule: High, subject to indexing/name limitations.

No reviewed earlier rejection notice identifies CFMG: High, subject to the same caveat.

Another PC relationship was affirmatively rejected: Very High.

CFMG MSA was therefore deemed assumed on May 9, 2025: High-confidence documentary/legal inference.

Wellpath LLC remained applicable contracting post-restructuring manager: High.

A new public assignment to New WPCC Parent was required: Not supported.

New WPCC Parent acquired CFMG physician stock: Not established.

CFMG expressly consented to the assumption: Unknown.

CFMG board independently deliberated about continuing Wellpath: Unknown from public record.

CFMG stock-transfer restriction agreement survived through Article V.F: Plausible and important inference; not yet proven from the exact instrument.

Bankruptcy makes the control-instrument question more urgent#

the prior analysis indicates that the CFMG MSA most likely continued through Wellpath’s Chapter 11 under the Plan’s blanket assumption mechanism.

The 2019 assignment also placed stock-transfer restrictions in the Wellpath LLC relationship.

The confirmed Plan contains broad language treating assumed contracts as including related agreements and interests unless separately rejected.

This creates a plausible path by which stock-control rights could have continued after May 9, 2025.

But the precise bankruptcy treatment of the CFMG stock agreement remains unknown.

Questions:

• Was the stock agreement separately scheduled?

• Was it considered an executory contract?

• Was it considered an organizational document?

• Was it amended at emergence?

• Did lender ownership alter any rights?

• Did the physician shareholder sign a reaffirmation?

These questions should be treated as Plan implementation issues, not merely historical corporate questions.

Why third-party descriptions of Wellpath owning CFMG carry limited weight#

Some county, media, labor, plaintiff, and advocacy materials describe CFMG as:

• owned by Wellpath;

• acquired by Wellpath;

• absorbed into Wellpath;

• formerly CFMG.

These statements are useful evidence of public operational identity and confusion.

They are weak evidence of actual stock ownership when contradicted by:

• CFMG professional-corporation status;

• bankruptcy treatment;

• Wellpath physician-ownership representations;

• Hallman’s no-overlap statement.

The Lake County Grand Jury’s statement that CFMG is owned by Wellpath is a useful example.

It is an official local-government report and therefore meaningful evidence of what County oversight personnel understood.

But it is not a stock ledger.

The public record should label such descriptions:

governmental-client characterization, not independently verified corporate ownership.

Conclusion#

A public attorney-facing formulation can state:

California litigation does not support the proposition that CFMG simply became Wellpath, nor does it support treating the two organizations as operational strangers. Post-bankruptcy cases repeatedly confirm that CFMG remained a separate professional corporation and non-debtor entity, while earlier and contemporaneous litigation also documents substantial operational integration. In \_Smith\_, CFMG accepted a case-specific stipulation treating CFMG and Wellpath as the same entity for all intents and purposes, and the court later held CFMG to that position. In \_D.M.\_, the discovery record reflects a representation that the entities were effectively the same with respect to records, employees, and other functions. By contrast, \_Pugh\_, \_J.S.\_, \_Reynolds\_, and \_Hernandez\_ document the juridical distinction that became critical after Wellpath's bankruptcy. \_Overfield\_ adds sworn physician-employment evidence: CFMG's corporate witness was a Wellpath HR executive who testified both that CFMG paid its employees and Wellpath supplied HR support, and that a CFMG physician was terminated by management working for Wellpath. The same witness denied that the termination involved the physician's clinical judgment. Taken together, the cases establish separateness and integration simultaneously. They do not yet resolve who possessed final authority when administration crossed into physician-reserved professional decisions.

That is the correct litigation synthesis at this stage.

Permanent wording / correction rules#

• Never conflate California Forensic Medical Group, Incorporated with Wellpath CFMG, Inc. f/k/a CFMG Holdings Corp.

• Never call Bazzel, Medrano, Kennedy, Taranath, Herr, Fithian, or another physician a CFMG shareholder without stock evidence.

• Do not state that H.I.G. directly purchased CFMG professional-corporation stock absent acquisition/stock records.

• Do not treat Wellpath bankruptcy language referring to “ownership interests” as an admission that Wellpath owned CFMG stock.

• Do not say the 2025 Plan assigned the CFMG MSA “to the lenders.” Current best reconstruction is continued Wellpath LLC counterparty + Plan assumption/revesting + new upstream ownership.

• Treat Art Center and Carbon Health as California legal/enforcement comparators, not adjudications against CFMG.

• Treat county phrases such as “CFMG/Wellpath,” “now Wellpath,” and “dba Wellpath” as evidence of client/public understanding, not dispositive corporate genealogy.

• Treat \*Smith\*’s same-entity stipulation as binding in that case, not universal merger/alter-ego proof.

• Treat Reynolds , Johnson , Pugh , J.S. , Yang , and similar post-bankruptcy corrections as strong entity-separateness evidence.

• Treat Rule 30(b)(6) use of a Wellpath employee as institutional-knowledge evidence, not automatic alter ego.

• Always distinguish participation , recommendation , approval , veto , implementation , and blocking power .

VI. Why the Issue Matters#

The stakes are practical rather than semantic. Counties need to know which entity is accountable for contracted performance; clinicians need to know where professional authority resides; courts and regulators need entity-specific evidence rather than brand shorthand; and the public needs a record that distinguishes corporate continuity from operational integration. Those distinctions become most important when the actors disagree, when a contract changes hands, when a professional decision conflicts with an economic preference, or when litigation requires a precise answer to who had authority to act.

Corporate disclosures — a subproject inside the litigation census#

The following N.D. Cal. matters have docket metadata that should be verified against the filed Rule 7.1 / interested-entity PDF:

• Beckner v. County of Santa Cruz — CFMG appears in docket metadata as “Corporate Parent” of Wellpath LLC.

• Sand v. County of Monterey — similar “Corporate Parent” language.

• Avila v. County of Monterey — similar language.

• Estate of Scott Strieter v. County of Sonoma — “Other Affiliate” language.

• later CFMG cases — reverse affiliate descriptions may appear.

Why county contracts are different from litigation positions#

A litigation filing is written to win a dispute.

A county contract is written to buy healthcare.

That distinction makes county records unusually valuable.

County procurement files can reveal:

• the bidder;

• the legal contracting party;

• the entity signing the agreement;

• the person signing;

• the entity receiving notices;

• the entity required to maintain insurance;

• the entity indemnifying the County;

• the proposed organizational chart;

• local and regional management;

• staffing requirements;

• medical-director responsibilities;

• clinical-quality requirements;

• EHR obligations;

• physician credentialing;

• pharmacy;

• utilization review;

• claims handling;

• payroll;

• employee relations;

• subcontractors;

• and whether Wellpath is identified as brand, manager, MSO, affiliate, successor, or contractor.

The client-side record is especially important because California counties were not passive observers. They negotiated and monitored the correctional-health programs.

If a county expressly understood that CFMG was the professional contractor and Wellpath the MSO, that is powerful evidence of the intended structure.

If another county called CFMG “now Wellpath,” “dba Wellpath,” or “dba Wellpath Management, Inc.,” that is powerful evidence of public operational identity , but not necessarily accurate corporate law.

The correct analysis is therefore:

What did the contract actually say, and what did the County staff report say?

Those can differ.

VII. Falsification Tests and Evidentiary Limits Note#

The record does not support be read as establishing an unproven motive, an undisclosed shareholder, an unlawful medical override, or a legal conclusion that a court or regulator has not made. The strongest version of the thesis is the one that survives the missing-document test: identify the instrument, minutes, ledger, delegation, approval record, or disagreement event that would materially change the conclusion, then state what has and has not been found. If later primary evidence contradicts a proposition stated here, the correction should be made at the proposition level rather than defended through branding or organizational shorthand.

VIII. Related Articles#

• Article 028 — The Missing Stock-Transfer Agreement

• Article 030 — Who Chose the Successor Physician? Reconstructing Fithian → Herr → Bazzel

• Article 027 — Officer Is Not Owner: The Most Important Corporate-Governance Correction in the Record

The proposition to be tested#

The central proposition in this article is not that every appearance of the Wellpath name proves control, nor that formal CFMG separateness ends the inquiry. The proposition to be tested is narrower: How should repeated defense-side Rule 7.1 parent disclosures be reconciled with bankruptcy and affiliate records? A serious legal brief should state that proposition before discussing motive, liability, or remedy because the same document can be highly probative on one dimension and nearly irrelevant on another.

For this subject, the principal evidentiary dimensions are Rule 7.1 disclosure, corporate parent terminology, ownership anomaly, and bankruptcy reconciliation. The source spine identified in the current public record is: Beckner/Sand/Avila disclosures; Strieter; Venegas; bankruptcy org chart; current physician-ownership description. Those sources should not be pooled as though they were interchangeable. A county contract speaks most reliably to the county's counterparty and purchased obligations. A management agreement speaks to contractual allocation between the professional corporation and manager. A court order speaks to the matter actually adjudicated. A party filing or corporate announcement remains a representation unless independently adopted or found by a tribunal.

Governance evidence must distinguish office, employment, management title, board membership, shareholder status, delegated authority, and signature authority. These categories can overlap in one person without becoming legally interchangeable. The relevant capacity must be identified for each act. The practical advantage of that method is that it prevents a common failure in complex-enterprise investigations: using a true fact about one relationship as proof of a different relationship. A shared brand may show integration; a W-2 may show payroll identity; a contract signature may show authority to bind a corporation; an officer title may show corporate office. None automatically proves stock ownership or final clinical authority.

The charging or enforcement threshold, if any regulator ever considered one, would therefore require an evidence chain rather than a collage: identify the protected or regulated function; identify the actor with formal authority; reconstruct the first operative decision; identify the person or entity that could approve, reject, modify, or reverse it; and verify who implemented the result. Until that chain is complete, the proper classification is evidence, inference, or unresolved question—not adjudicated fact.

Weighing the evidence#

The evidentiary hierarchy for Did CFMG Own Wellpath LLC? The Federal 'Corporate Parent' Disclosure Anomaly should begin with contemporaneous primary instruments and end with retrospective shorthand. Executed contracts, amendments, assignments, board resolutions, authenticated corporate records, court orders, government payroll or labor records, and formal agency records ordinarily deserve more weight on the proposition they were created to establish than marketing language or later summaries. Even among primary materials, however, purpose matters. A contract can establish contractual rights without proving that those rights were exercised; a tax record can establish reporting without deciding every common-law employer factor; a bankruptcy schedule can establish debtor treatment without answering professional-governance questions for a nondebtor corporation.

The article's existing record illustrates why that hierarchy matters.ithin its evidentiary lane. Did CFMG Own Wellpath LLC? The Federal 'Corporate Parent' Disclosure Anomaly is a governance inquiry, not a title-matching exercise. Corporate office, medical leadership, stock ownership, enterprise employment, and practical decision authority are treated as distinct evidentiary categories. The record is strongest where those categories converge in executed documents and weakest where succession or ownership instruments remain unavailable.

A prosecutor, defense lawyer, regulator, or investigative editor should ask five questions of every source: Who created it? What legal or business purpose did it serve? What date and entity does it concern? Is the statement a recital, operative term, allegation, stipulation, finding, or marketing representation? What independent record could confirm or contradict it? Applying those questions consistently is more valuable than multiplying citations that all derive from the same underlying assertion.

This also defines how contradictions should be handled. When two records use different labels, the first step is not to accuse one of being false. The first step is to determine whether the records were answering different questions. Only after normalizing entity, date, capacity, forum, and purpose should a remaining contradiction be treated as substantive. That discipline makes the article stronger for both sides because it identifies where the record genuinely conflicts and where the conflict is merely semantic.

How each source is used#

The following public authorities are tied to defined propositions in this article. They are not interchangeable: each is cited for the institutional purpose it can actually prove, and none is treated as a universal finding about ownership, employment, liability, or professional control.

• Federal Rule of Civil Procedure 7.1, Disclosure Statement. Used here as the federal corporate-disclosure framework relevant to testing parent, subsidiary, and interested-entity terminology without converting disclosure language into a universal ownership finding.
• Madrid et al. v. County of Tulare, E.D. Cal. No. 1:24-cv-00351, ECF No. 37 (July 2025). Used here as a public filing useful for testing parent/subsidiary nomenclature against the bankruptcy ownership record and the CFMG management agreements.
• Johnson v. County of Alameda, N.D. Cal. No. 3:23-cv-04069, ECF No. 76 (Mar. 2026). Used here as a public litigation correction distinguishing CFMG from Wellpath Management, Inc. and the debtor-side entities.
• 2012 CFMG Management Services Agreement — California Forensic Medical Group, Incorporated and California Forensic Management Group, Inc., Dec. 31, 2012. Used here as operative baseline for the allocation of management functions, physician-reserved responsibilities, and the manager/professional-corporation relationship.
• 2019 Assignment of Management Services Agreement, effective Jan. 1, 2019 — CFMG remained the Company while Wellpath LLC became the Manager. Used here as dated evidence of management succession without, by itself, eliminating CFMG's separate professional-corporation identity.
• Wellpath, 'Wellpath Announces Creation of a New Operating Division in California,' Mar. 13, 2026. Used here as Wellpath's current public description of its California operating layer and its relationship with CFMG.
• California Corporations Code § 13401.5, Moscone-Knox Professional Corporation Act. Used here as the professional-corporation ownership and licensed-person framework relevant to shareholder, director, officer, and professional-employee questions.

Sources and authorities#

1. Federal Rule of Civil Procedure 7.1, Disclosure Statement
2. Madrid et al. v. County of Tulare, E.D. Cal. No. 1:24-cv-00351, ECF No. 37 (July 2025) — https://docs.justia.com/cases/federal/district-courts/california/caedce/1%3A2024cv00351/443900/37
3. Johnson v. County of Alameda, N.D. Cal. No. 3:23-cv-04069, ECF No. 76 (Mar. 2026) — https://docs.justia.com/cases/federal/district-courts/california/candce/3%3A2023cv04069/416712/76
4. 2012 CFMG Management Services Agreement — California Forensic Medical Group, Incorporated and California Forensic Management Group, Inc., Dec. 31, 2012 — https://www.prisonlegalnews.org/news/publications/california-forensic-medical-group-incorporated-management-services-agreement/
5. 2019 Assignment of Management Services Agreement, effective Jan. 1, 2019 — CFMG remained the Company while Wellpath LLC became the Manager — https://www.prisonlegalnews.org/media/publications/California\_Forensic\_Medical\_Group\_Assignment\_of\_Management\_Services\_Agreement.pdf
6. Wellpath, 'Wellpath Announces Creation of a New Operating Division in California,' Mar. 13, 2026 — https://wellpathcare.com/2026/03/13/wellpath-announces-creation-of-a-new-operating-division-in-california-appoints-new-highly-experienced-leader/
7. California Corporations Code § 13401.5, Moscone-Knox Professional Corporation Act — https://leginfo.legislature.ca.gov/faces/codes\_displaySection.xhtml?lawCode=CORP&sectionNum=13401.5.

Citation rule: These sources support only the propositions identified in the article and source analysis. A party filing remains a party position unless adopted by a court; a corporate announcement remains a corporate representation; a contract proves allocated rights but not necessarily implementation; and a regulator's guidance or enforcement position is not an adjudication against CFMG unless a cited matter says so.